AI Is Compressing Every Layer of Biotech at the Same Time
In the week of March 29 to April 5, 2026, four simultaneous signals confirmed that AI is compressing every layer of the biotech value chain at once. Insilico Medicine published Phase IIa results for the first wholly AI-designed drug. NVIDIA expanded BioNeMo for life sciences. Tempus AI reported a 27% improvement in trial patient identification. EvolutionaryScale released ESM Cambrian. The cumulative effect on development timelines and commercial NPV is multiplicative, not additive.
AI Is Compressing Every Layer of Biotech at the Same Time Read More »